Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) Director Sells 3,650 Shares of Stock
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) Director Rita Balice-Gordon sold 3,650 shares of the stock in a transaction on Friday, December 5th. The shares were sold at an average price of $47.03, for a total value of $171,659.50. Following the sale, the director owned 52,629 shares of the company’s stock, valued at $2,475,141.87. […]
9 Dec 22:27 · The Markets Daily